- 专利标题: PANCREATIC ENDOCRINE PROGENITOR CELLS AND USE THEREOF
-
申请号: US17761445申请日: 2020-09-17
-
公开(公告)号: US20220347226A1公开(公告)日: 2022-11-03
- 发明人: Yi Zeng , Daisong Wang
- 申请人: CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
- 申请人地址: CN Shanghai
- 专利权人: CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
- 当前专利权人: CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
- 当前专利权人地址: CN Shanghai
- 优先权: CNPCT/CN2019/106093 20190917
- 国际申请: PCT/CN2020/115794 WO 20200917
- 主分类号: A61K35/39
- IPC分类号: A61K35/39 ; C12N5/071 ; A61P3/10
摘要:
Provided herein are endocrine progenitor cells and organoids derived from adult islets in vitro, as well as methods for making and using the same. The compositions are useful for treating or preventing diabetes, other diseases or disorders characterized by impaired islet function, and symptoms thereof.
信息查询
IPC分类: